AHSG and myocardial infarction: Lower fetuin-A levels are associated with mortality and CVD events in cohorts with end-stage renal disease (ESRD) [8,9], while a population based study linked high plasma fetuin-A levels to an increased risk of myocardial infarction (MI) and ischemic stroke (IS) [10].